BACKGROUND: Psoriasis is an inflammatory, IL-17-driven skin disease in which autoantigen-induced CD8+ T cells have been identified as pathogenic drivers. OBJECTIVE: Our study focused on comprehensively characterizing the phenotypic variation of CD8+ T cells in psoriatic lesions. METHODS: We used single-cell RNA sequencing to compare CD8+ T-cell transcriptomic heterogeneity between psoriatic and healthy skin. RESULTS: We identified 11 transcriptionally diverse CD8+ T-cell subsets in psoriatic and healthy skin. Among several inflammatory subsets enriched in psoriatic skin, we observed 2 Tc17 cell subsets that were metabolically divergent, were developmentally related, and expressed CXCL13, which we found to be a biomarker of psoriasis severity and which achieved comparable or greater accuracy than IL17A in a support vector machine classifier of psoriasis and healthy transcriptomes. Despite high coinhibitory receptor expression in the Tc17 cell clusters, a comparison of these cells with melanoma-infiltrating CD8+ T cells revealed upregulated cytokine, cytolytic, and metabolic transcriptional activity in the psoriatic cells that differed from an exhaustion program. CONCLUSION: Using high-resolution single-cell profiling in tissue, we have uncovered the diverse landscape of CD8+ T cells in psoriatic and healthy skin, including 2 nonexhausted Tc17 cell subsets associated with disease severity.
BACKGROUND: Psoriasis is an inflammatory, IL-17-driven skin disease in which autoantigen-induced CD8+ T cells have been identified as pathogenic drivers. OBJECTIVE: Our study focused on comprehensively characterizing the phenotypic variation of CD8+ T cells in psoriatic lesions. METHODS: We used single-cell RNA sequencing to compare CD8+ T-cell transcriptomic heterogeneity between psoriatic and healthy skin. RESULTS: We identified 11 transcriptionally diverse CD8+ T-cell subsets in psoriatic and healthy skin. Among several inflammatory subsets enriched in psoriatic skin, we observed 2 Tc17 cell subsets that were metabolically divergent, were developmentally related, and expressed CXCL13, which we found to be a biomarker of psoriasis severity and which achieved comparable or greater accuracy than IL17A in a support vector machine classifier of psoriasis and healthy transcriptomes. Despite high coinhibitory receptor expression in the Tc17 cell clusters, a comparison of these cells with melanoma-infiltrating CD8+ T cells revealed upregulated cytokine, cytolytic, and metabolic transcriptional activity in the psoriatic cells that differed from an exhaustion program. CONCLUSION: Using high-resolution single-cell profiling in tissue, we have uncovered the diverse landscape of CD8+ T cells in psoriatic and healthy skin, including 2 nonexhausted Tc17 cell subsets associated with disease severity.
Authors: Johann E Gudjonsson; Jun Ding; Andrew Johnston; Trilokraj Tejasvi; Andrew M Guzman; Rajan P Nair; John J Voorhees; Goncalo R Abecasis; James T Elder Journal: J Invest Dermatol Date: 2010-03-11 Impact factor: 8.551
Authors: Rei Watanabe; Ahmed Gehad; Chao Yang; Laura L Scott; Jessica E Teague; Christoph Schlapbach; Christopher P Elco; Victor Huang; Tiago R Matos; Thomas S Kupper; Rachael A Clark Journal: Sci Transl Med Date: 2015-03-18 Impact factor: 17.956
Authors: Kristian Reich; Kim A Papp; Andrew Blauvelt; Stephen K Tyring; Rodney Sinclair; Diamant Thaçi; Kristine Nograles; Anish Mehta; Nicole Cichanowitz; Qing Li; Kenneth Liu; Carmen La Rosa; Stuart Green; Alexa B Kimball Journal: Lancet Date: 2017-06-06 Impact factor: 79.321
Authors: Hagma H Workel; Joyce M Lubbers; Roland Arnold; Thalina M Prins; Pieter van der Vlies; Kim de Lange; Tjalling Bosse; Inge C van Gool; Florine A Eggink; Maartje C A Wouters; Fenne L Komdeur; Elisabeth C van der Slikke; Carien L Creutzberg; Arjan Kol; Annechien Plat; Mark Glaire; David N Church; Hans W Nijman; Marco de Bruyn Journal: Cancer Immunol Res Date: 2019-03-14 Impact factor: 11.151
Authors: Hung-Rong Yen; Timothy J Harris; Satoshi Wada; Joseph F Grosso; Derese Getnet; Monica V Goldberg; Kai-Li Liang; Tullia C Bruno; Kristin J Pyle; Siaw-Li Chan; Robert A Anders; Cornelia L Trimble; Adam J Adler; Tzou-Yien Lin; Drew M Pardoll; Ching-Tai Huang; Charles G Drake Journal: J Immunol Date: 2009-11-16 Impact factor: 5.422
Authors: Tran H Do; Feiyang Ma; Priscila R Andrade; Rosane Teles; Bruno J de Andrade Silva; Chanyue Hu; Alejandro Espinoza; Jer-En Hsu; Chun-Seok Cho; Myungjin Kim; Jingyue Xi; Xianying Xing; Olesya Plazyo; Lam C Tsoi; Carol Cheng; Jenny Kim; Bryan D Bryson; Alan M O'Neill; Marco Colonna; Johann E Gudjonsson; Eynav Klechevsky; Jun Hee Lee; Richard L Gallo; Barry R Bloom; Matteo Pellegrini; Robert L Modlin Journal: Sci Immunol Date: 2022-07-22
Authors: Jared Liu; Hsin-Wen Chang; Robby Grewal; Daniel D Cummins; Audrey Bui; Kristen M Beck; Sahil Sekhon; Di Yan; Zhi-Ming Huang; Timothy H Schmidt; Eric J Yang; Isabelle M Sanchez; Mio Nakamura; Shrishti Bhattarai; Quinn Thibodeaux; Richard Ahn; Mariela Pauli; Tina Bhutani; Michael D Rosenblum; Wilson Liao Journal: JID Innov Date: 2021-12-30
Authors: Yale Liu; Hao Wang; Mark Taylor; Christopher Cook; Alejandra Martínez-Berdeja; Jeffrey P North; Paymann Harirchian; Ashley A Hailer; Zijun Zhao; Ruby Ghadially; Roberto R Ricardo-Gonzalez; Roy C Grekin; Theodora M Mauro; Esther Kim; Jaehyuk Choi; Elizabeth Purdom; Raymond J Cho; Jeffrey B Cheng Journal: Sci Immunol Date: 2022-04-15
Authors: Di Yan; Johann E Gudjonsson; Stephanie Le; Emanual Maverakis; Olesya Plazyo; Christopher Ritchlin; Jose U Scher; Roopesh Singh; Nicole L Ward; Stacie Bell; Wilson Liao Journal: J Invest Dermatol Date: 2021-07-22 Impact factor: 8.551